Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions.
In a child with the hemolytic uremic syndrome, plasma 6 keto-prostaglandin F1 alpha levels remained undetectable throughout the acute phase of the disease. The patient's plasma failed to stimulate prostacyclin production by "exhausted" rat aorta rings. In vitro study of the patient's vessels indicated that they retained the capacity to synthesize prostacyclin from exogenous arachidonic acid but that their endogenous arachidonic acid stores were either depleted or non-available. The response to repeated infusion of exogenous prostacyclin was equivocal, suggesting that abnormal prostacyclin metabolism in the hemolytic uremic syndrome may not be the only factor in its pathogenesis.
D002675:Child, Preschool; D011464:Epoprostenol / Q000378:metabolism*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000378:metabolism*; D006801:Humans; D011453:Prostaglandins / Q000378:metabolism*
D011453:Prostaglandins; D011464:Epoprostenol